FRANCISCO RODRIGO, M.D.; JEFFREY SHIDEMAN, B.S.; RICHARD McHUGH, Ph.D.; THEODORE BUSELMEIER, M.D.; CARL KJELLSTRAND, M.D., F.A.C.P.
We studied the influence of both a high-glucose-concentration dialysate (717 mg/dl) and intravenous mannitol (1g/kg) on the serum osmolality changes in stable patients on chronic dialysis. During regular dialysis, serum osmolality fell 10 mosmol/kg H2O. This fall was reduced to 5.2 mosmol/kg H2O when the high-glucose-concentration dialysate was used, and to 4.3 mosmol/kg H2O when intravenous mannitol was used. When the two methods were combined, the serum osmolality fall was reduced to 1.7 mosmol/kg H2O. The clinical signs of disequilibrium declined (from 67% to 10%) in parallel with the decline in serum osmolality changes. This fall was independent of the ultrafiltration rate. A high-glucoseconcentration dialysate and intravenous mannitol can each reduce the osmolality changes that occur during hemodialysis, but when used alone, intravenous mannitol is more effective of the two. The reduction of osmolality changes also leads to reduction of the mild clinical signs usually associated with disequilibrium.
RODRIGO F, SHIDEMAN J, McHUGH R, BUSELMEIER T, KJELLSTRAND C. Osmolality Changes during Hemodialysis: Natural History, Clinical Correlations, and Influence of Dialysate Glucose and Intravenous Mannitol. Ann Intern Med. ;86:554–561. doi: 10.7326/0003-4819-86-5-554
Download citation file:
Published: Ann Intern Med. 1977;86(5):554-561.
Nephrology, Renal Replacement Therapy.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use